Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 12:24 pm Purchase | 2024-09-30 | 13G | Galmed Pharmaceuticals Ltd. GLMD | CVI Investments, Inc. | 167,258 9.900% | 167,258 (New Position) | Filing History |
| 2024-09-20 2:18 pm Sale | 2024-09-19 | 13G | Galmed Pharmaceuticals Ltd. GLMD | Otsuka Masaya | 0 0.000% | -63 (Position Closed) | Filing History |
| 2024-09-20 2:17 pm Purchase | 2024-09-18 | 13G | Galmed Pharmaceuticals Ltd. GLMD | Otsuka Masaya | 63 9.900% | 63 (New Position) | Filing History |
| 2024-02-14 2:14 pm Purchase | 2023-12-31 | 13G | Galmed Pharmaceuticals Ltd. GLMD | CVI Investments, Inc. | 34,569 9.900% | 17,271 (+99.85%) | Filing History |
| 2024-02-14 09:52 am Unchanged | 2023-12-31 | 13G | Galmed Pharmaceuticals Ltd. GLMD | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-12 4:15 pm Purchase | 2023-12-31 | 13G | Galmed Pharmaceuticals Ltd. GLMD | Baharaff Allen | 26,459 6.200% | 26,459 (New Position) | Filing History |
| 2023-07-21 10:12 am Purchase | 2023-07-14 | 13G | Galmed Pharmaceuticals Ltd. GLMD | CVI Investments, Inc. | 17,298 9.900% | 17,298 (New Position) | Filing History |
| 2023-02-14 12:03 pm Sale | 2022-12-31 | 13G | Galmed Pharmaceuticals Ltd. GLMD | BIOTECHNOLOGY VALUE FUND L P | 9,665 6.900% | -333 (-3.34%) | Filing History |
| 2023-02-07 4:15 pm Purchase | 2022-12-31 | 13G | Galmed Pharmaceuticals Ltd. GLMD | Baharaff Allen | 25,335 17.300% | 818 (+3.34%) | Filing History |
| 2022-02-14 08:14 am Sale | 2021-12-31 | 13G | Galmed Pharmaceuticals Ltd. GLMD | Nantahala Capital Management, LLC | 1,655 1.200% | -9,050 (-84.54%) | Filing History |
| 2022-02-11 4:30 pm Purchase | 2021-12-31 | 13G | Galmed Pharmaceuticals Ltd. GLMD | Baharaff Allen | 24,517 16.900% | 736 (+3.10%) | Filing History |
| 2022-01-27 4:32 pm Sale | 2021-12-31 | 13G | Galmed Pharmaceuticals Ltd. GLMD | Ibex Investors LLC | 1,975 1.400% | -6,497 (-76.68%) | Filing History |
| 2021-02-16 06:23 am Purchase | 2020-12-31 | 13G | Galmed Pharmaceuticals Ltd. GLMD | Nantahala Capital Management, LLC | 10,705 9.000% | 10,705 (New Position) | Filing History |
| 2021-02-12 4:30 pm Purchase | 2020-12-31 | 13G | Galmed Pharmaceuticals Ltd. GLMD | Baharaff Allen | 23,781 19.300% | 457 (+1.96%) | Filing History |
| 2021-02-12 4:13 pm Sale | 2020-12-31 | 13G | Galmed Pharmaceuticals Ltd. GLMD | BIOTECHNOLOGY VALUE FUND L P | 9,998 8.400% | -182 (-1.79%) | Filing History |
| 2021-01-15 11:16 am Purchase | 2020-12-31 | 13G | Galmed Pharmaceuticals Ltd. GLMD | Ibex Investors LLC | 8,472 7.200% | 2,601 (+44.30%) | Filing History |
| 2020-07-28 3:22 pm Purchase | 2020-07-27 | 13G | Galmed Pharmaceuticals Ltd. GLMD | Ibex Investors LLC | 5,871 5.010% | 5,871 (New Position) | Filing History |
| 2020-02-14 3:18 pm Sale | 2019-12-31 | 13G | Galmed Pharmaceuticals Ltd. GLMD | BIOTECHNOLOGY VALUE FUND L P | 10,180 8.700% | -256 (-2.45%) | Filing History |
| 2020-02-13 4:30 pm Purchase | 2019-12-31 | 13G | Galmed Pharmaceuticals Ltd. GLMD | Baharaff Allen | 23,324 19.200% | 546 (+2.40%) | Filing History |
| 2020-02-13 10:11 am Sale | 2019-12-31 | 13G | Galmed Pharmaceuticals Ltd. GLMD | 683 Capital Management LLC | 4,444 3.800% | -3,056 (-40.74%) | Filing History |